Keeping You Connected

The SCCMA keeps you up to date on the latest news,
policy developments, and events

Local News

rss

CMA statement on Supreme Court's order granting stay in medication abortion case

Donaldo Hernandez, M.D., the president of the California Medical Association (CMA), issued the following statement in response to the Supreme Court order granting a stay in the lawsuit against the U.S. Food and Drug Administration (FDA) over its approval of mifepristone. “The U.S. Supreme Court’s order today to stay the lower court rulings is great news, as it means mifepristone will remain available in the interim for the lives and welfare of millions of people who might need this drug that has been FDA-approved as safe and effective for 23 years. “As ...

California Launches Initiative to Improve Quality of Life for People with Dementia

CALIFORNIA LAUNCHES INITIATIVE TO IMPROVE QUALITY OF LIFE FOR PEOPLE LIVING WITH DEMENTIA New Cognitive Health Assessment and Warmline Help Practitioners Identify Dementia Primary care providers in California have a new dementia screening tool, the cognitive health assessment, available to help identify cognitive decline in their patients (age 65 and older) and determine next steps. Dementia Care Aware, a statewide initiative led by the Department of Health Care Services (DHCS), provides training on this new assessment and support through a warmline to help primary care providers successfully screen for dementia in ...

CHCF Shares Resources to Support Palliative Care in Public Hospitals

For people with serious illness, palliative care programs provide essential services to address the complex physical and emotional burdens that come with such illnesses. These programs are available in both inpatient and outpatient settings. Yet even with ample evidence about the positive impact of these services, leaders in palliative care programs often have to make the case about the value of these services. California Health Care Foundation's (CHCF)  collection Resources to Support Palliative Care in Public Hospitals includes information and tools to help leaders of palliative care programs at public health ...

DEA publishes guidance on new training requirements for prescribers of controlled substances

On March 28, 2023, the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) released recommendations and the U.S. Drug Enforcement Administration (DEA) issued specific guidance on how practitioners can meet the new training requirements for DEA-registered prescribers of controlled substances.  The new law requires all prescribers of schedule II – V controlled substances to meet a one-time eight-hour training requirement on identifying, treating, and managing patients with opioid or other substance use disorders. Many California-licensed physicians may have already met the new DEA requirements because California requires similar education. While the California Medical Association (CMA) did not ...

SCC HEALTH ADVISORY: Xylazine Presence in Illicit Drug Supply (P2)

DATE: April 3, 2023 TO: All Healthcare Providers FROM: Michelle Jorden, MD, F-ABMDI Chief Medical Examiner - Coroner Akanksha Vaidya, MD, MPH Assistant Public Health Officer HEALTH ADVISORY: XYLAZINE PRESENCE IN ILLICIT DRUG SUPPLY Xylazine, a non-opioid agent developed as a veterinary tranquilizer, has been increasingly detected in the nation’s illicit opioid supply. Xylazine has been associated with fatal overdoses and chronic wounds, with areas in the Northeast USA being heavily impacted. The U.S. Drug Enforcement Administration (DEA) Laboratory System reported that in 2022, approximately 23% of fentanyl powder and 7% of fentanyl pills seized by the DEA contained xylazine. In Santa ...